These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model. Wang HE; Liao AH; Deng WP; Chang PF; Chen JC; Chen FD; Liu RS; Lee JS; Hwang JJ J Nucl Med; 2004 Feb; 45(2):302-8. PubMed ID: 14960653 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: a validation study for the theranostic approach using [ Watanabe T; Hattori Y; Ohta Y; Ishimura M; Nakagawa Y; Sanada Y; Tanaka H; Fukutani S; Masunaga SI; Hiraoka M; Ono K; Suzuki M; Kirihata M BMC Cancer; 2016 Nov; 16(1):859. PubMed ID: 27821116 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the total distribution volume of Romanov V; Isohashi K; Alobthani G; Beshr R; Horitsugi G; Kanai Y; Naka S; Watabe T; Shimosegawa E; Hatazawa J Ann Nucl Med; 2020 Mar; 34(3):155-162. PubMed ID: 31808134 [TBL] [Abstract][Full Text] [Related]
6. 4-Borono-2- Ishiwata K Ann Nucl Med; 2019 Apr; 33(4):223-236. PubMed ID: 30820862 [TBL] [Abstract][Full Text] [Related]
7. Positron emission tomography and [18F]BPA: a perspective application to assess tumour extraction of boron in BNCT. Menichetti L; Cionini L; Sauerwein WA; Altieri S; Solin O; Minn H; Salvadori PA Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S351-4. PubMed ID: 19410471 [TBL] [Abstract][Full Text] [Related]
8. A unique in vivo assessment of 4-[10B]borono-L-phenylalanine in tumour tissues for boron neutron capture therapy of malignant melanomas using positron emission tomography and 4-borono-2-[18F]fluoro-L-phenylalanine. Ishiwata K; Shiono M; Kubota K; Yoshino K; Hatazawa J; Ido T; Honda C; Ichihashi M; Mishima Y Melanoma Res; 1992 Sep; 2(3):171-9. PubMed ID: 1450671 [TBL] [Abstract][Full Text] [Related]
9. Similar T/N ratio between Lin YC; Chou FI; Yang BH; Chang CW; Chen YW; Hwang JJ Ann Nucl Med; 2020 Jan; 34(1):58-64. PubMed ID: 31650410 [TBL] [Abstract][Full Text] [Related]
10. FBPA PET in boron neutron capture therapy for cancer: prediction of (10)B concentration in the tumor and normal tissue in a rat xenograft model. Hanaoka K; Watabe T; Naka S; Kanai Y; Ikeda H; Horitsugi G; Kato H; Isohashi K; Shimosegawa E; Hatazawa J EJNMMI Res; 2014 Dec; 4(1):70. PubMed ID: 25621196 [TBL] [Abstract][Full Text] [Related]
12. Non-invasive estimation of Yoshimoto M; Honda N; Kurihara H; Hiroi K; Nakamura S; Ito M; Shikano N; Itami J; Fujii H Cancer Sci; 2018 May; 109(5):1617-1626. PubMed ID: 29498142 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption. Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic analysis and uptake of 18F-FBPA-Fr after ultrasound-induced blood-brain barrier disruption for potential enhancement of boron delivery for neutron capture therapy. Yang FY; Chang WY; Li JJ; Wang HE; Chen JC; Chang CW J Nucl Med; 2014 Apr; 55(4):616-21. PubMed ID: 24525207 [TBL] [Abstract][Full Text] [Related]
15. Uptake of 4-borono-2-[18F]fluoro-L-phenylalanine in sporadic and neurofibromatosis 2-related schwannoma and meningioma studied with PET. Havu-Aurén K; Kiiski J; Lehtiö K; Eskola O; Kulvik M; Vuorinen V; Oikonen V; Vähätalo J; Jääskeläinen J; Minn H Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):87-94. PubMed ID: 16896669 [TBL] [Abstract][Full Text] [Related]
16. MicroPET-based pharmacokinetic analysis of the radiolabeled boron compound [18F]FBPA-F in rats with F98 glioma. Chen JC; Chang SM; Hsu FY; Wang HE; Liu RS Appl Radiat Isot; 2004 Nov; 61(5):887-91. PubMed ID: 15308163 [TBL] [Abstract][Full Text] [Related]
17. Macro- and microdistributions of boron drug for boron neutron capture therapy in an animal model. Lin YC; Hwang JJ; Wang SJ; Yang BH; Chang CW; Hsiao MC; Chou FI Anticancer Res; 2012 Jul; 32(7):2657-64. PubMed ID: 22753723 [TBL] [Abstract][Full Text] [Related]
18. On the applicability of [ Grunewald C; Sauberer M; Filip T; Wanek T; Stanek J; Mairinger S; Rollet S; Kudejova P; Langer O; Schütz C; Blaickner M; Kuntner C Nucl Med Biol; 2017 Jan; 44():83-89. PubMed ID: 27837726 [TBL] [Abstract][Full Text] [Related]
19. Correlation of (18)F-BPA and (18)F-FDG uptake in head and neck cancers. Tani H; Kurihara H; Hiroi K; Honda N; Yoshimoto M; Kono Y; Murakami R; Kumita S; Arai Y; Itami J Radiother Oncol; 2014 Nov; 113(2):193-7. PubMed ID: 25466367 [TBL] [Abstract][Full Text] [Related]
20. Relationship between the uptake of Watanabe Y; Kurihara H; Itami J; Sasaki R; Arai Y; Sugimura K Radiat Oncol; 2017 Jan; 12(1):17. PubMed ID: 28088230 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]